Notified bodies showed significantly differing practices when issuing quotations to manufacturers for specific conformity assessment activities. As a result, manufacturers are not provided with a reliable estimation of the overall requested services and costs. To harmonise notified bodies’ practices, this Regulation should specify the minimum information notified bodies should request to issue a quotation, to ensure that the related following applications for conformity assessment activities are not rejected because they are incomplete or because the device is outside the scope of the notified body’s designation. Notifies bodies should ask information on the device(s), their intended purpose, any specific characteristics or specific technologies or processes used, to allow them to verify they are designated for the corresponding codes, provided for in Commission Implementing Regulation (EU) 2017/2185 [Commission Implementing Regulation (EU) 2017/2185 of 23 November 2017 on the list of codes and corresponding types of devices for the purpose of specifying the scope of the designation as notified bodies in the field of medical devices under Regulation (EU) 2017/745 of the European Parliament and of the Council and in vitro diagnostic medical devices under Regulation (EU) 2017/746 of the European Parliament and of the Council (OJ L 309, 24.11.2017, p. 7, ELI: http://data.europa.eu/eli/reg_impl/2017/2185/oj).].
Recital 5, Regulation (EU) 2026/977
In forcesince 4 May 2026